Pregnancy outcomes following different types of bariatric surgery: A national cohort study.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
May 2021
Historique:
received: 22 01 2021
accepted: 25 02 2021
pubmed: 12 3 2021
medline: 15 5 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

To assess the impact of type of bariatric surgery on pregnancy outcomes. This is a national prospective observational study using the UK Obstetric Surveillance System (UKOSS). Data collection was undertaken in 200 consultant-led NHS maternity units between November 2011 and October 2012 (gastric banding), and April 2014 and March 2016 (gastric bypass and sleeve gastrectomy). Participants were pregnant women following gastric banding (n = 127), gastric bypass (n = 134) and sleeve gastrectomy (n = 29). Maternal and perinatal outcomes were compared using generalised linear and linear mixed models. Maternal outcomes included gestational weight gain, pre-eclampsia, gestational diabetes, anaemia, surgical complications. Perinatal outcomes included birthweight, small/large for gestational age (SGA/LGA), preterm birth, stillbirth. Maternal: Women pregnant after gastric banding and sleeve gastrectomy had a lower risk of anaemia compared with gastric bypass (banding (16 %) vs bypass (39 %): p = 0.002, sleeve (21 %) vs bypass: p = 0.04). Gestational diabetes risk was lower after gastric banding compared with gastric bypass (7 % vs 16 %, p = 0.03) despite women with banding having significantly greater weight at booking as well as gestational weight gain. Women pregnant after gastric banding and sleeve gastrectomy had a lower risk of surgical complications than after gastric bypass (banding (0.9 %) vs bypass (11.4 %): p = 0.03, sleeve (0.0 %) vs bypass: p = 0.06). Perinatal: Infants born to mothers after gastric banding had a higher birthweight than those born to mothers after gastric bypass (mean difference = 260 g (125-395), p < 0.001). Infants were more likely to be LGA if their mothers had gastric banding compared with gastric bypass or sleeve gastrectomy (banding (21 %) vs bypass (5 %): p = 0.006; banding vs sleeve (3 %): p = 0.03). Risk of preterm birth was higher in women with gastric banding compared with gastric bypass (13 % vs 8 %, p = 0.04). Women planning bariatric surgery should be counselled regarding the differing impacts of different types of procedure on any future pregnancy. Pre-existing gastric bypass is associated with higher rates of potentially serious surgical complications during pregnancy.

Identifiants

pubmed: 33706225
pii: S0301-2115(21)00110-X
doi: 10.1016/j.ejogrb.2021.02.031
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-17

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Katie Cornthwaite (K)

Women's Health Department, North Bristol NHS Trust, UK; Translational Health Sciences, University of Bristol, UK. Electronic address: kc17995@bristol.ac.uk.

Chetan Prajapati (C)

Translational Health Sciences, University of Bristol, UK.

Erik Lenguerrand (E)

Translational Health Sciences, University of Bristol, UK.

Marian Knight (M)

National Perinatal Epidemiology Unit, University of Oxford, UK.

Natalie Blencowe (N)

Population Health Sciences, University of Bristol, UK.

Andrew Johnson (A)

Diabetes and Endocrinology Department, North Bristol NHS Trust, UK.

Tim Draycott (T)

Women's Health Department, North Bristol NHS Trust, UK.

Dimitrios Siassakos (D)

Elizabeth Garett Anderson Institute for Women's Health, University College London, UK; NIHR Biomedical Research Centre at University College London Hospital, UK; Wellcome/EPSRC Centre for Surgical and Interventional Sciences (WEISS), UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH